A major reinsurance firm based in Europe makes direct venture stage investments in strategically relevant healthcare startups through a corporate venture capital team, and also invests in life science funds and incubators around the world. The firm invests opportunistically, with a focus on early stage opportunities.
The firm invests strategically in startups that could potentially drive growth in its life and health insurance businesses. In life sciences, the firm is interested in the convergence of life science and insurance tech, and invests in areas such as genomics, digital health, and diagnostics (including diagnostic products focused on consumers as users). The firm is open to investing in any indication area.
The firm’s investments are strategic in nature, and the firm can potentially act as a strategic partner to a portfolio company by supporting product deployment among its network in the health insurance space.
If you are interested in more information about this investor and other investors tracked by LSN, please email: mandates@lifesciencenation.com.
Leave a Reply